<p>BRMS1 downregulation is a poor prognostic biomarker in anaplastic thyroid carcinoma patients</p>
Cited by 3
Related Papers
2016 Chinese expert consensus and guidelines for the diagnosis and treatment of papillary thyroid microcarcinoma
|Cancer Biology and Medicine|2017|124
LDHA induces EMT gene transcription and regulates autophagy to promote the metastasis and tumorigenesis of papillary thyroid carcinoma
|Cell Death and Disease|2021|100
Antitumor effects of anlotinib in thyroid cancer
|Endocrine Related Cancer|2018|92
METTL3 inhibition induced by M2 macrophage-derived extracellular vesicles drives anti-PD-1 therapy resistance via M6A-CD70-mediated immune suppression in thyroid cancer
|Cell Death and Differentiation|2023|78
The RING-finger ubiquitin E3 ligase TaPIR1 targets TaHRP1 for degradation to suppress chloroplast function
|Nature Communications|2024|23